These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17588771)

  • 1. Interindividual differences in phytochemical metabolism and disposition.
    Lampe JW; Chang JL
    Semin Cancer Biol; 2007 Oct; 17(5):347-53. PubMed ID: 17588771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II drug metabolizing enzymes.
    Jancova P; Anzenbacher P; Anzenbacherova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Jun; 154(2):103-16. PubMed ID: 20668491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Methodology and Application for the Metabolism of Phytochemical Compounds-An Update Covering the Period of 2009-2014.
    Cao W; Yi L; Cao J; Hu SS; Li P
    Curr Drug Metab; 2014; 15(10):966-87. PubMed ID: 25828593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals.
    Possemiers S; Bolca S; Verstraete W; Heyerick A
    Fitoterapia; 2011 Jan; 82(1):53-66. PubMed ID: 20655994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I and Phase II enzyme polymorphisms and childhood cancer.
    Swinney R; Hsu S; Tomlinson G
    J Investig Med; 2006 Sep; 54(6):303-20. PubMed ID: 17134614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet, genetic polymorphisms, detoxification, and health risks.
    Lampe JW
    Altern Ther Health Med; 2007; 13(2):S108-11. PubMed ID: 17405687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements.
    Gurley BJ
    Planta Med; 2012 Sep; 78(13):1478-89. PubMed ID: 22322396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention.
    Saracino MR; Lampe JW
    Nutr Cancer; 2007; 59(2):121-41. PubMed ID: 18001207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CE and CEC analysis of phytochemicals in herbal medicines.
    Chen XJ; Zhao J; Wang YT; Huang LQ; Li SP
    Electrophoresis; 2012 Jan; 33(1):168-79. PubMed ID: 22139595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications.
    Guillemette C; Lévesque É; Rouleau M
    Clin Pharmacol Ther; 2014 Sep; 96(3):324-39. PubMed ID: 24922307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.
    Cerda A; Hirata MH; Hirata RD
    Drug Metabol Drug Interact; 2014; 29(3):153-77. PubMed ID: 24744305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging technologies for improving phytochemical bioavailability: benefits and risks.
    Gurley BJ
    Clin Pharmacol Ther; 2011 Jun; 89(6):915-9. PubMed ID: 21544076
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver genomic responses to ciguatoxin: evidence for activation of phase I and phase II detoxification pathways following an acute hypothermic response in mice.
    Morey JS; Ryan JC; Bottein Dechraoui MY; Rezvani AH; Levin ED; Gordon CJ; Ramsdell JS; Van Dolah FM
    Toxicol Sci; 2008 Jun; 103(2):298-310. PubMed ID: 18353800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of selected genes of toxication and detoxication pathways in peripheral blood lymphocytes as a biomarker for predicting toxicity of environmental chemicals.
    Sharma A; Saurabh K; Yadav S; Jain SK; Parmar D
    Int J Hyg Environ Health; 2013 Nov; 216(6):645-51. PubMed ID: 23273579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
    Schulz T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indian studies on genetic polymorphisms and cancer risk.
    Bag A; Jyala NS; Bag N
    Indian J Cancer; 2012; 49(1):144-62. PubMed ID: 22842182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of garlic supplements and phytochemicals on the ADMET properties of drugs.
    Berginc K; Kristl A
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):295-310. PubMed ID: 22313151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions.
    Kumar YS; Adukondalu D; Sathish D; Vishnu YV; Ramesh G; Latha AB; Reddy PC; Sarangapani M; Rao YM
    Drug Metabol Drug Interact; 2010; 25(1-4):3-16. PubMed ID: 21417789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of CZE for analysis of phytochemical bioactive compounds.
    Li P; Li SP; Wang YT
    Electrophoresis; 2006 Dec; 27(23):4808-19. PubMed ID: 17136720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.